Respiri is an e-Health SaaS company supporting respiratory health management. Its world-first technology detects wheeze, a typical symptom of asthma, COPD and respiratory disease to provide an objective measure of airway limitation. wheezo, Respiri's innovative technology, comprises an eHealth app c... Respiri is an e-Health SaaS company supporting respiratory health management. Its world-first technology detects wheeze, a typical symptom of asthma, COPD and respiratory disease to provide an objective measure of airway limitation. wheezo, Respiri's innovative technology, comprises an eHealth app combined with a simple, easy to use, handheld device. wheezo is the first smart device to help improve asthma management by monitoring wheeze and documenting symptoms, signs, triggers, weather conditions and medication use. The asthma management platform also facilitates the sharing of data with caregivers, physicians, and other health care professionals. Respiri's mission is to help improve quality of life for hundreds of millions of children and adults around the world and dramatically reduce hospital admissions and the economic burden of asthma. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0.0557 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0.0557 | 0 | 0 | 0 | CS |
12 | 0.0542 | 3613.33333333 | 0.0015 | 0.0557 | 0.0015 | 0 | 0 | CS |
26 | 0.0542 | 3613.33333333 | 0.0015 | 0.0557 | 0.0015 | 200 | 0.0015 | CS |
52 | 0.04966 | 822.185430464 | 0.00604 | 0.0557 | 0.0015 | 15143 | 0.00991981 | CS |
156 | 0.0257 | 85.6666666667 | 0.03 | 0.06 | 0.0015 | 16813 | 0.03263569 | CS |
260 | 0.0257 | 85.6666666667 | 0.03 | 0.06 | 0.0015 | 16813 | 0.03263569 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約